For instance, their activation relies on antigen presentation by dendritic cells (DCs); dysfunctional DCs in NSCLC lead to impairments in CD8+ T cells, thereby weakening their antitumor activity [9]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.